155 related articles for article (PubMed ID: 36112827)
1. Development of a Molecular Blood-Based Immune Signature Classifier as Biomarker for Risks Assessment in Lung Cancer Screening.
Fortunato O; Huber V; Segale M; Cova A; Vallacchi V; Squarcina P; Rivoltini L; Suatoni P; Sozzi G; Pastorino U; Boeri M
Cancer Epidemiol Biomarkers Prev; 2022 Nov; 31(11):2020-2029. PubMed ID: 36112827
[TBL] [Abstract][Full Text] [Related]
2. Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screening.
Sestini S; Boeri M; Marchiano A; Pelosi G; Galeone C; Verri C; Suatoni P; Sverzellati N; La Vecchia C; Sozzi G; Pastorino U
Oncotarget; 2015 Oct; 6(32):32868-77. PubMed ID: 26451608
[TBL] [Abstract][Full Text] [Related]
3. Clinical utility of a plasma-based miRNA signature classifier within computed tomography lung cancer screening: a correlative MILD trial study.
Sozzi G; Boeri M; Rossi M; Verri C; Suatoni P; Bravi F; Roz L; Conte D; Grassi M; Sverzellati N; Marchiano A; Negri E; La Vecchia C; Pastorino U
J Clin Oncol; 2014 Mar; 32(8):768-73. PubMed ID: 24419137
[TBL] [Abstract][Full Text] [Related]
4. Serum and blood based biomarkers for lung cancer screening: a systematic review.
Chu GCW; Lazare K; Sullivan F
BMC Cancer; 2018 Feb; 18(1):181. PubMed ID: 29439651
[TBL] [Abstract][Full Text] [Related]
5. Baseline computed tomography screening and blood microRNA predict lung cancer risk and define adequate intervals in the BioMILD trial.
Pastorino U; Boeri M; Sestini S; Sabia F; Milanese G; Silva M; Suatoni P; Verri C; Cantarutti A; Sverzellati N; Corrao G; Marchianò A; Sozzi G
Ann Oncol; 2022 Apr; 33(4):395-405. PubMed ID: 35091076
[TBL] [Abstract][Full Text] [Related]
6. A lung cancer risk classifier comprising genome maintenance genes measured in normal bronchial epithelial cells.
Yeo J; Crawford EL; Zhang X; Khuder S; Chen T; Levin A; Blomquist TM; Willey JC
BMC Cancer; 2017 May; 17(1):301. PubMed ID: 28464886
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of Low-Dose Computed Tomography With a Plasma-Based Biomarker for Lung Cancer Screening in China.
Zhao Z; Wang Y; Wu W; Yang Y; Du L; Dong H
JAMA Netw Open; 2022 May; 5(5):e2213634. PubMed ID: 35608858
[TBL] [Abstract][Full Text] [Related]
8. Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non-Small Cell Lung Cancer.
Li B; Cui Y; Diehn M; Li R
JAMA Oncol; 2017 Nov; 3(11):1529-1537. PubMed ID: 28687838
[TBL] [Abstract][Full Text] [Related]
9. Serum mass profile signature as a biomarker of early lung cancer.
Widlak P; Pietrowska M; Polanska J; Marczyk M; Ros-Mazurczyk M; Dziadziuszko R; Jassem J; Rzyman W
Lung Cancer; 2016 Sep; 99():46-52. PubMed ID: 27565913
[TBL] [Abstract][Full Text] [Related]
10. Potential circulating miRNA signature for early detection of NSCLC.
Arab A; Karimipoor M; Irani S; Kiani A; Zeinali S; Tafsiri E; Sheikhy K
Cancer Genet; 2017 Oct; 216-217():150-158. PubMed ID: 29025589
[TBL] [Abstract][Full Text] [Related]
11. A classifier integrating plasma biomarkers and radiological characteristics for distinguishing malignant from benign pulmonary nodules.
Lin Y; Leng Q; Jiang Z; Guarnera MA; Zhou Y; Chen X; Wang H; Zhou W; Cai L; Fang H; Li J; Jin H; Wang L; Yi S; Lu W; Evers D; Fowle CB; Su Y; Jiang F
Int J Cancer; 2017 Sep; 141(6):1240-1248. PubMed ID: 28580707
[TBL] [Abstract][Full Text] [Related]
12. Pan-cancer characterization of cell-free immune-related miRNA identified as a robust biomarker for cancer diagnosis.
Wu P; Zhang C; Tang X; Li D; Zhang G; Zi X; Liu J; Yin E; Zhao J; Wang P; Wang L; Li R; Wu Y; Sun N; He J
Mol Cancer; 2024 Feb; 23(1):31. PubMed ID: 38347558
[TBL] [Abstract][Full Text] [Related]
13. What makes a blood cell based miRNA expression pattern disease specific?--a miRNome analysis of blood cell subsets in lung cancer patients and healthy controls.
Leidinger P; Backes C; Dahmke IN; Galata V; Huwer H; Stehle I; Bals R; Keller A; Meese E
Oncotarget; 2014 Oct; 5(19):9484-97. PubMed ID: 25344866
[TBL] [Abstract][Full Text] [Related]
14. Development of a Protein Biomarker Panel to Detect Non-Small-Cell Lung Cancer in Korea.
Jung YJ; Katilius E; Ostroff RM; Kim Y; Seok M; Lee S; Jang S; Kim WS; Choi CM
Clin Lung Cancer; 2017 Mar; 18(2):e99-e107. PubMed ID: 27836219
[TBL] [Abstract][Full Text] [Related]
15. Mutational Profile from Targeted NGS Predicts Survival in LDCT Screening-Detected Lung Cancers.
Verri C; Borzi C; Holscher T; Dugo M; Devecchi A; Drake K; Sestini S; Suatoni P; Romeo E; Sozzi G; Pastorino U; Boeri M
J Thorac Oncol; 2017 Jun; 12(6):922-931. PubMed ID: 28302568
[TBL] [Abstract][Full Text] [Related]
16. [Lung cancer screening in high-risk subjects: early detection with LDCT and risk stratification using miRNA-based blood test].
Sestini S; Boeri M; Marchianò A; Silva M; Calareso G; Galeone C; Sozzi G; Pastorino U
Epidemiol Prev; 2016; 40(1 Suppl 1):42-50. PubMed ID: 26951732
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening.
Mensah M; Borzi C; Verri C; Suatoni P; Conte D; Pastorino U; Orazio F; Sozzi G; Boeri M
J Vis Exp; 2017 Oct; (128):. PubMed ID: 29155727
[TBL] [Abstract][Full Text] [Related]
18. A novel gene expression signature in peripheral blood mononuclear cells for early detection of colorectal cancer.
Nichita C; Ciarloni L; Monnier-Benoit S; Hosseinian S; Dorta G; Rüegg C
Aliment Pharmacol Ther; 2014 Mar; 39(5):507-17. PubMed ID: 24428642
[TBL] [Abstract][Full Text] [Related]
19. Value of low-dose spiral CT combined with circulating miR-200b and miR-200c examinations for lung cancer screening in physical examination population.
Wang YZ; Lv YB; Li GY; Zhang DQ; Gao Z; Gai QZ
Eur Rev Med Pharmacol Sci; 2021 Oct; 25(19):6123-6130. PubMed ID: 34661272
[TBL] [Abstract][Full Text] [Related]
20. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
